Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
07/2006
07/25/2006US7081536 Complexes; used for catalyst
07/20/2006WO2006075888A1 Oxazole hydroxamic acid derivatives and use thereof
07/20/2006WO2006074798A1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006WO2006074797A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006WO2006074501A1 Peptidic compounds
07/20/2006WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
07/20/2006WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
07/20/2006WO2005070904A3 Sulfonamide compounds and methods of making and using the same
07/20/2006US20060161007 Oxazole and thiazole combinatorial libraries
07/20/2006US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide
07/20/2006US20060160795 Administering benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, extracted from immature corn plants, in oral, parenteral, sustained release or transdermal dosage forms; fibromyalgia, sleep apnea; hypoglycemic, antidiabetic and antiarthritic agents
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006DE102004060227B3 Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten A process for the production of oxazoles by condensation of aromatic aldehydes with α-ketoximes to N-oxides and subsequent reaction with activated acid derivatives
07/20/2006CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006CA2594707A1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids
07/20/2006CA2594389A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/19/2006EP1681287A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1681286A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1680408A2 Ccr3 receptor antagonists
07/19/2006EP1194146B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
07/19/2006CN1805945A Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1805923A Benzamide derivative or salt thereof
07/19/2006CN1803802A Method for synthesizing oxazole pyridone compound
07/18/2006US7078422 Activator for peroxisome proliferator-activated receptor
07/18/2006US7078421 Substituted phenylacetic acids
07/18/2006US7078406 using derivatives of 2-(4'-sulfamoylphenyl)-5-(4'-dimethylaminophenyl)oxazoles to monitor a cell environment; improved utility in thermal shift bioassays
07/18/2006US7078404 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
07/18/2006CA2244417C Optically active bisoxazoline compounds, production and use thereof
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006WO2005090302A3 Palladium catalyzed indolization of 2-bromo or chloroanilines
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154977 Therapeutic molecules and methods-1
07/13/2006US20060154922 Muscarinic agonists
07/13/2006US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
07/13/2006US20060153784 Bis(o-allyloxy)anilinocarbonyl)-benzene or -naphthalene intermediates for preparing bis(benzoxazolyl)-benzene or -naphthalene sunscreens
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1335923B1 Condensed pyridoindole derivatives
07/12/2006CN1263748C A process for the preparation of bis-benzazolyl compounds
07/11/2006US7074776 Exposing bacterium to heterocyclic comound for controlling growth
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006069811A2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them
07/06/2006WO2006069685A1 Substituted oxyarenes
07/06/2006WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/06/2006WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2006US20060149077 4-Naphthyl-substituted, e.g., 2,2-bis[2-[(4S)-(1-naphthyl)-5,5-dimethyloxazoline]]propane; catalyst for preparing cyclopropanecarboxylates from prochiral olefins; amidating a 1-amino-1-naphthyl-2-(cyclo)alkanol with a dicarboxylate or diacyl halide and cyclizing the diamide formed with a Lewis acid
07/06/2006US20060149076 Copper catalyzed arylation
07/06/2006US20060148869 Halogenated biaryl heterocyclic compounds and methods of making and using the same
07/06/2006US20060148042 Biotransformation to produce stereospecific drug; reacting a substituted arylaldehydes and 2-oxoacids using 2-hydroxy-3-oxoacid synthases; bacterial origin, yeast enzyme, Escherichia coli, fungal enzyme, and plant; pure enantiomers (R)-phenylacetyl carbinol
07/06/2006DE102004061037A1 Oxazolinmischung Oxazolinmischung
07/06/2006CA2592585A1 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them
07/06/2006CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/05/2006EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
07/05/2006EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy
07/05/2006EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
07/05/2006EP1371649B1 Process for producing 5-substituted oxazole and 1,5-disubstituted imidazole compounds
07/05/2006CN1798743A N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
07/05/2006CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns
07/05/2006CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative
07/04/2006US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents
07/04/2006US7071221 Heterocyclic oxime compounds
07/04/2006CA2418227C Process for the preparation of 5-hydroxymethyl 2-oxazolidinone and novel intermediate
07/04/2006CA2418200C 5-trityloxymethyl-oxazolidinones and process for the preparation thereof
07/04/2006CA2250840C Antivirally active heterocyclic azahexane derivatives
06/2006
06/29/2006WO2006067472A1 Parp inhibitors
06/29/2006WO2006067086A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes
06/29/2006WO2006066694A1 Method for the production of oxazoles by condensing aromatic aldehydes with a-ketoximes to n-oxides and then reacting the same with activated acid derivatives
06/29/2006US20060142612 Arylsulfonamide derivatives
06/29/2006US20060142357 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2006US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands
06/29/2006CA2590494A1 Method for the production of oxazoles by condensing aromatic aldehydes with a-ketoximes to n-oxides and then reacting the same with activated acid derivatives
06/29/2006CA2589667A1 Vitamin d receptor modulators
06/28/2006EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
06/28/2006EP1674445A1 Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same
06/28/2006EP1673370A1 A novel crystalline form of linezolid
06/28/2006EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/28/2006EP1673356A1 Substituted benzylaminoalkylene heterocycles
06/28/2006EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor
06/28/2006EP1485057B9 Derivatives of azaspiro compounds for the treatment of pain
06/28/2006CN1795175A Acetylene derivatives as inhibitors of histone deacetylase
06/28/2006CN1793130A 2,2', 6,6'-tetraoxazoline diphenyl ligancy and preparation process thereof
06/28/2006CN1261428C Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
06/28/2006CN1261418C 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides
06/28/2006CN1261405C Optically active amine derivative and method of synthesis
06/27/2006US7067675 reduction of the ketone group of 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-alkyl- or phenyl-2-oxa- or thiazolidin-one, -thione or -alkylimine with (-)-DIP chloride to obtain the corresponding 5-hydroxy- derivative
06/27/2006US7067542 Diaminediols for the treatment of Alzheimer's disease
06/27/2006US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection
06/27/2006US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase
06/22/2006WO2006066173A2 Novel mch receptor antagonists
06/22/2006WO2006063999A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006US20060135784 Process for producing 3-amino-2-hydroxypropionic acid derivatives
06/22/2006US20060135782 Benzazole analogues and uses thereof
06/22/2006US20060135781 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
06/22/2006US20060135770 PARP inhibitors
06/22/2006US20060135579 amino alcohols; selective ribonucleic acid (RNA) binding agents; detecting the binding of small molecules to T-box antiterminator model mRNAs; screening for microbiocidal drug targets; use disinfecting; antiviral, anti-HIV; e.g. use of 1,2-dihydroxy-3-amino-4-phenylbutane
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 210